Frederique Ph.D. Menzaghi - Aug 30, 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Scientific Off,SVP-R&D
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Aug 30, 2021
Transactions value $
-$54,627
Form type
4
Date filed
9/1/2021, 06:07 PM
Previous filing
Aug 26, 2021
Next filing
Dec 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$54.6K -3.85K -2.65% $14.20 141K Aug 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person.